First, two years in remission is genuinely meaningful — and the fact that treatment worked before is important information your oncologist will use going forward. When MCL comes back (called relapsed MCL), there are real options available.
Here are some treatments commonly used for relapsed MCL:
- BTK inhibitors like Show Full Answer
First, two years in remission is genuinely meaningful — and the fact that treatment worked before is important information your oncologist will use going forward. When MCL comes back (called relapsed MCL), there are real options available.
Here are some treatments commonly used for relapsed MCL:
- BTK inhibitors like acalabrutinib (Calquence), zanubrutinib (Brukinsa), or pirtobrutinib (Jaypirca)
- Venetoclax (Venclexta) — sometimes used off-label
- CAR T-cell therapy — such as brexucabtagene autoleucel (Tecartus) or lisocabtagene maraleucel (Breyanzi)
- Chemotherapy regimens that weren't used in your first treatment
- Immunotherapy combinations like lenalidomide plus rituximab It's also worth asking your oncologist about clinical trials, since newer and more targeted treatments for relapsed MCL are actively being studied and may be available to you.
A few important things to keep in mind:
- Your overall health and how your body responded to prior treatment will guide which option is best
- Some treatments, like a stem cell transplant, may still be on the table depending on your health status
- Staying in close contact with your care team about any new symptoms is really important right now
Don't hesitate to ask your oncologist directly: *"Are there newer treatments available that might work better for my situation?"* You deserve a full picture of what's possible.
July 20
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
